Log In
BCIQ
Print this Print this
 

Galidesivir (BCX4430)

  Manage Alerts
Collapse Summary General Information
Company BioCryst Pharmaceuticals Inc.
DescriptionBroad-spectrum viral RNA polymerase inhibitor
Molecular Target
Mechanism of ActionRNA polymerase inhibitor; Antiviral agent
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$22.0M

$5.0M

0


 Deals Details
Get a free BioCentury trial today